Abstract:Abstract Background The small number of samples and the curse of dimensionality hamper the better application of deep learning techniques for disease classification. Additionally, the performance of clustering-based feature selection algorithms is still far from being satisfactory due to their limitation in using unsupervised learning methods. To enhance interpretability and overcome this problem, we developed a novel feature selection algorithm. In the meantime, complex genomic data brought great challenges for the identification of biomarkers and therapeutic targets. The current some feature selection methods have the problem of low sensitivity and specificity in this field. Results In this article, we designed a multi-scale clustering-based feature selection algorithm named MCBFS which simultaneously performs feature selection and model learning for genomic data analysis. The experimental results demonstrated that MCBFS is robust and effective by comparing it with seven benchmark and six state-of-the-art supervised methods on eight data sets. The visualization results and the statistical test showed that MCBFS can capture the informative genes and improve the interpretability and visualization of tumor gene expression and single-cell sequencing data. Additionally, we developed a general framework named McbfsNW using gene expression data and protein interaction data to identify robust biomarkers and therapeutic targets for diagnosis and therapy of diseases. The framework incorporates the MCBFS algorithm, network recognition ensemble algorithm and feature selection wrapper. McbfsNW has been applied to the lung adenocarcinoma (LUAD) data sets. The preliminary results demonstrated that higher prediction results can be attained by identified biomarkers on the independent LUAD data set, and we also structured a drug-target network which may be good for LUAD therapy. Conclusions The proposed novel feature selection method is robust and effective for gene selection, classification, and visualization. The framework McbfsNW is practical and helpful for the identification of biomarkers and targets on genomic data. It is believed that the same methods and principles are extensible and applicable to other different kinds of data sets.

Improving Tumor Clustering Based on Gene Selection

Nim: A Node Influence Based Method for Cancer Classification

Gene selection and cancer classification using Monte Carlo and nonnegative matrix factorization

Gene selection using independent variable group analysis for tumor classification

Multi-scale supervised clustering-based feature selection for tumor classification and identification of biomarkers and targets on genomic data

A Cancer Gene Selection Algorithm Based on the K-S Test and CFS

A Fast Quantum Clustering Approach for Cancer Gene Clustering

Double selection based semi-supervised clustering ensemble for tumor clustering from gene expression profiles

Bi-level gene selection of cancer by combining clustering and sparse learning

Sparse P-Norm Nonnegative Matrix Factorization for Clustering Gene Expression Data.

Tumor Classification Using Non-negative Matrix Factorization

On -Divergence Based Nonnegative Matrix Factorization for Clustering Cancer Gene Expression Data

On α-divergence based nonnegative matrix factorization for clustering cancer gene expression data

A Novel Approach for Single Gene Selection Using Clustering and Dimensionality Reduction

Multiclass Cancer Classification by Using Fuzzy Support Vector Machine and Binary Decision Tree with Gene Selection

Parameters Selection in Gene Selection Using Gaussian Kernel Support Vector Machines by Genetic Algorithm

Identification of Tumor Mutation Burden, Microsatellite Instability, and Somatic Copy Number Alteration Derived Nine Gene Signatures to Predict Clinical Outcomes in STAD.

Gene Selection Algorithm Based on Correlation Analysis

Sparse Orthogonal Nonnegative Matrix Factorization for Identifying Differentially Expressed Genes and Clustering Tumor Samples.

Feature Genes Selection Using Fuzzy Rough Uncertainty Metric for Tumor Diagnosis.

Optimize Deep Learning Models for Prediction of Gene Mutations Using Unsupervised Clustering